Trimi vs Lttl: Two Budget GLP-1 Programs Compared for 2026

Two compounded GLP-1 programs, both promising the same thing: a legit weight-loss shot without the pharmacy-counter sticker shock. Put Trimi vs Lttl side by side and the gap comes down to about thirty dollars a month and one word — commitment. Trimi runs compounded semaglutide at $99 a month; Lttl starts at $129. On tirzepatide the spread is wider, $125 against $199. If you’re picking a budget GLP-1 program for 2026 and money is the deciding factor, that’s the whole ballgame. Except it isn’t, quite, and the rest of this is why.

The price tags, straight up

Both keep the same idea at their core: one flat monthly price, no dose-based markups, everything folded in — clinician review, refills, shipping. Neither bills insurance. Both are FSA/HSA eligible. Where they split is the entry deal and the strings attached.

	Trimi	Lttl
Compounded semaglutide	$99/month	From $129/month
Compounded tirzepatide	$125/month	From $199/month
Microdose option	Not listed	From $109/month
Intro discount	None	Up to $140 off first month
Commitment for lowest price	Annual plan	Cancel anytime, no contract
Shipping	Free overnight (2–4 days)	Free expedited
Support	24/7 care team	24/7, board-certified clinicians

Read the bottom two rows twice. Trimi’s $99 is its annual-plan price, so that headline number assumes you’re staying a year. Lttl charges more per month but lets you cancel whenever and knocks up to $140 off month one. So the “cheaper” label flips depending on how long you actually last. Somebody who quits at week six may pay less with Lttl’s discount than with Trimi’s annual math. Somebody who goes the distance saves real money with Trimi.

Trimi vs Lttl on what you actually get

Trimi’s whole personality is focus. Two medications, one flat price, approved within about 24 hours, free overnight shipping that usually lands in two to four days. It doesn’t try to be a longevity clinic. For a lot of people that’s the appeal — fewer choices, less to think about, cheaper.

Lttl goes the other way. Same flat-dose pricing, but the menu is bigger: standard doses, microdosed versions from $109, and a longevity line running $79 to $129. If you think you might branch out past a weight-loss shot, Lttl gives you room to without opening a second account. The catch is you pay for that breadth up front — its base weight-loss prices simply start higher.

Honestly, the support and onboarding feel similar from the outside. Both run a quick online assessment, both have licensed U.S. clinicians sign off before anything ships, both promise round-the-clock messaging. Neither one is making you sit on hold. The difference isn’t service quality; it’s how wide a net each one casts.

What a full year actually runs you

Sticker prices are easy to compare; annual totals are what hit your account. Stay on compounded semaglutide for twelve months and Trimi’s $99 works out to about $1,188 for the year. Lttl at $129, minus its first-month discount of up to $140, lands closer to $1,408 — call it a $220 difference over the year on semaglutide. On tirzepatide the gap widens: Trimi’s $125 is roughly $1,500 a year against Lttl’s $199, which even after the intro credit runs near $2,248. That’s a $700-plus spread.

Those are back-of-envelope figures, not quotes, and your real total shifts with dose changes and whatever promo is live when you sign up. But the direction is steady: the longer you stay, the more Trimi’s lower base price compounds in your favor. The shorter your run, the more Lttl’s no-commitment discount softens the blow. Match the plan to how long you honestly expect to stick with it.

The compounded caveat both share

Same asterisk sits under both programs. Compounded semaglutide and tirzepatide are not FDA-approved products — they’re mixed by a pharmacy, and a licensed prescriber has to decide the treatment is appropriate for you before it ships. That matters more now than it did a year ago: the FDA declared the semaglutide shortage resolved in February 2025, and routine bulk compounding wound down after that. A compounded GLP-1 can still reach you, but the prescriber’s judgment, not a checkout page, is what makes it happen. It’s a real cost difference from a $349 FDA-approved pen, not just a discount.

For scale on why either exists: roughly 42% of U.S. adults meet the clinical definition of obesity, and most weight-loss prescriptions still aren’t covered by insurance. Cash-pay programs like these two are built for exactly that squeeze.

Which budget GLP-1 program wins?

If your plan is straightforward — you want a semaglutide or tirzepatide shot, you’re fairly sure you’ll stick with it, and you want the lowest steady price — Trimi is the cleaner pick. $99 versus $129 adds up to $360 a year on semaglutide alone, and the stripped-down menu is a feature, not a gap. Pick Lttl if you’re not ready to commit to a full year, want that first-month discount to test the waters, or think you’ll eventually want microdosing or the longevity add-ons. We’d have liked Trimi to offer a no-contract monthly tier for the commitment-shy — that’s the one place Lttl’s flexibility clearly wins.

Frequently asked questions

Is Trimi cheaper than Lttl?

On the monthly rate, yes. Trimi’s compounded semaglutide is $99 versus Lttl’s $129, and tirzepatide is $125 versus $199. But Trimi’s lowest price is an annual plan, while Lttl lets you cancel anytime and takes up to $140 off your first month, so short-term users may come out closer than the sticker prices suggest.

Do Trimi or Lttl take insurance?

Neither bills insurance — both are cash-pay. The upside is that both are FSA/HSA eligible, so you can often use pre-tax dollars. There are no separate consult or membership fees on top of the monthly price at either.

Are the medications FDA-approved?

No. Both offer compounded semaglutide and tirzepatide, which are not FDA-approved products. A licensed U.S. clinician has to review your profile and decide the treatment is appropriate before it ships. That prescriber sign-off is required at both programs.

Which should I choose if I’m new to GLP-1s?

If you want to test the waters without a year-long commitment, Lttl’s cancel-anytime plan and first-month discount lower the risk. If you’re confident you’ll stay on and want the lowest ongoing price, Trimi’s $99 semaglutide is hard to beat. Either way, talk it through with the prescribing clinician first.